Objective: The aim of this study is to investigate the effect of body size on insulin-mediated, whole-body glucose uptake (M-value) in morbidly obese (MO) subjects, who have large amounts of fat mass. Furthermore, we aimed at verifying which surrogate insulin-sensitivity index can better substitute the euglycemic clamp values and whether the insulin secretion/insulin resistance index is meaningful also in MO subjects. Design: The study design is cross-sectional, case-control study of insulin sensitivityFassessed by different methodsFand insulin secretion. Subjects: One-hundred and sixty-eight subjects ca. 39 years old, with a body mass index (BMI) between 17 and 64 kg m -2 , underwent euglycemic hyperinsulinemic clamp and oral glucose tolerance test (OGTT) with surrogate measures of insulin sensitivity together with body composition by 3 H 2 O dilution. Insulin secretion rate (ISR) was measured at fast and after OGTT by C-peptide deconvolution. Results: The population was divided into quartiles of BMI. In the fourth quartile, the best insulin-sensitivity variable between M/I/kg FFM and M/I/kg bw was the latter, as shown by area under the receiver-operator characteristic (ROC) curve (0.85 vs 0.89). The best index to identify insulin-resistant individuals (lowest distribution quartile: M/I/kg bw p29.3 mmol min À1 kg À1 nmol l À1 ) were Matsuda index and oral glucose insulin sensitivity (OGIS), whereas fasting insulin concentration, QUICKI, and HOMA failed (ROC analysis). M-value declined exponentially as the BMI increased, whereas ISR linearly increased. The insulin secretion/insulin resistance index well applied to MO. Conclusion: In MO subjects, in which the fat mass is highly represented, fat-free mass cannot be considered the only determinant of insulin sensitivity, thus M-value should be normalized by total body weight. The best surrogates of insulin sensitivity measured by euglycemic clamp are Matsuda index and OGIS. BMI directly affects both insulin sensitivity and ISR and the insulin secretion/insulin resistance index is a valid model to correlate ISR with insulin sensitivity also in MO.
Introduction
The effect of body size on insulin-mediated, whole-body glucose uptake (M-value) has not been described clearly. Fat-free mass (FFM) is considered the 'metabolically active' component of the body weight (BW) and was initially used to adjust for between-individual differences in resting energy expenditure. [1] [2] [3] Successively, it was applied to measures of glucose uptake, such as the M-value, by many scientists [4] [5] [6] [7] including us. [8] [9] [10] However, although in normal weight or overweight individuals and even in obese subjects this normalization can be correct, as long as the fat mass (FM) increases up to approach or match the FFM component, this normalization can create errors in the evaluation of fundamental parameters of glucose and energy metabolism. In fact, although in lean individuals the glucose uptakeFassessed by radioactive 14 C-glucoseFinto the adipose tissue was found to account for 1-4% of the given glucose, this value increased up to 20% in obese subjects. 11, 12 In a recent study using positron emission tomography, in combination with [18F]fluoro-deoxy-glucose and [15O]-labeled water, Virtanen et al. 13 have shown that the average glucose uptake from total body adipose tissue (abdominal plus rest of the fat) was 13% of the given glucose during a euglycemic hyperinsulinemic clamp in obese individuals and 8% in non-obese subjects. In this study, the body mass index (BMI) of the obese subjects was 27-34 kg m -2
. 13 Thus, it is likely that in morbid obesity the glucose uptake from adipose tissue can reach considerable figures during the clamp.
To this end, we have conducted a control-cohort study in 168 subjects with a BMI ranging from 17 to 64 kg m -2 , in which glucose uptake was assessed by the euglycemic clamp and surrogate measures of insulin sensitivity together with body composition. The insulin secretion rate (ISR) was also computed, by C-peptide deconvolution, and correlated with body composition.
Materials and methods
A cross-sectional, case-control study was conducted in obese patients as compared with healthy volunteers at the day hospital of metabolic disorders of the Catholic University of Rome, Italy, over a period of 4 years, from January 2004 through December 2008, to assess insulin sensitivity and secretion and body composition. Overall, 168 subjects have been studied, whose BMI was distributed within a wide spectrum, ranging from 17 to 64 kg m -2
. Type 2 diabetic or impaired glucose tolerant subjects were excluded from this study.
The study protocol was approved by the Institutional Ethics Committee of the Catholic University of Rome. The nature and purpose of the study were carefully explained to all subjects before they provided their written consent to participate.
Body composition BW was measured to the nearest 0.1 kg with a beam scale and height to the nearest 0.5 cm using a stadiometer (Holatin, Crosswell, Wales, UK). Total body water was measured by the labeled water dilution method, and FFM and FM were calculated as described earlier. 14 
Euglycemic hyperinsulinemic clamp
Peripheral insulin sensitivity was evaluated by 2-h EHC. 15 After inserting a cannula in a dorsal hand vein for sampling arterialized venous blood and another in the antecubital fossa of the contralateral arm for infusions, the subjects rested in the supine position for at least 1 h. They were placed with one hand warmed in a heated-air box set at 60 1C to obtain arterialized blood samples. Insulin sensitivity, as the total insulin-mediated glucose uptake, was determined during a primed constant infusion of insulin (at the rate of 40 mU min -1 m -2
). The fasting plasma glucose concentration was maintained throughout the insulin infusion by means of a variable glucose infusion and blood glucose determinations every 5 min. Insulin sensitivity was determined by measuring the whole-body glucose clearance rate during steadystate euglycemic hyperinsulinemia.
Oral glucose tolerance test A standard 75-g oral glucose tolerance test (OGTT) was performed in each patient at baseline and after surgery as well as in each volunteer, with blood sampling at 0, 30, 60, 90, 120, 150, and 180 min.
Surrogate indices of insulin resistance
The HOMA-IR was used to calculate an index from the product of the fasting concentrations of plasma insulin (mU ml -1 ) and plasma glucose (mM) divided by 22.5. 16 The QUICKI proposed by Katz et al. 17 was calculated as follows:
1/[log (fasting plasma insulin) þ log (fasting plasma glucose)].
Fasting insulin was also used as an index of insulin resistance. Matsuda index 18 was defined by the following formula:
10 000
Insulin sensitivity was also evaluated by the oral glucose insulin sensitivity (OGIS) as proposed by Mari et al.
19
Insulin secretion rate The ISR was reconstructed from plasma C-peptide concentrations by the deconvolution method. 20 
Analytical procedures
Plasma glucose was measured by the glucose oxidase technique on a Beckman Glucose Analyzer (Beckman, Fullerton, CA, USA). Plasma insulin was assayed by microparticle enzyme immunoassay (Abbott, Pasadena, CA, USA). C-peptide was assayed by radioimmunoassay (MYRIA; Technogenetics, Milan, Italy).
Statistics
Variables are presented as means ± s.d. The significance of the mean differences was tested with Student's t-test. Statistical significance was considered at the level of Po0.05. The subjects were divided into quartiles according to their BMI. To approximate the Gaussian data distribution and to straighten the relationships between variables, the data were transformed by power transformation to minimum skewness in individual dimensions where appropriate.
The slopes and intercepts of the estimated regression lines when subdivided by quartiles were compared with each other by ANOVA. As standard ANOVA does not incorporate the error in the independent variables, we also confirmed the ANOVA results by performing individual t-tests on the corrected slopes and y intercepts with Bonferroni's correction (results not shown), which yielded similar results.
Comparison between groups was performed by either an independent sample t-test or by ANOVA with Bonferroni's post hoc analysis.
Pearson's correlation coefficients (r) were tested using onesample t-tests against a null hypothesis that the population correlation coefficient (r) ¼ 0.
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The receiver-operator characteristic (ROC) curve was used to comparatively evaluate the ability of the insulin-sensitivity measures as means for the identification of morbidly obese (MO) subjects.
In an attempt to find the best surrogate method for assessing insulin resistance, ROC curves were developed. The curves describe the ability of a surrogate measure to separate true-positive (that is sensitivity) from false-positive (that is, specificity) insulin resistance. The test accuracy is determined by the area under the ROC curve with a value of 0.5 indicating no significant relation and a value of 1 indicating a perfect relation. In this study, ROC curves were used to describe the accuracy with which levels of fasting insulin, HOMA-IR, QUICKI, Matsuda index, or OGIS can identify individuals with insulin resistance, defined as an M/I/kg bw value below the lowest quartile of the total M/I/kg bw distribution.
Data were partitioned into k mutually exclusive clusters. Each cluster in the partition was defined by its member Fat mass and insulin sensitivity in morbid obesity D Gniuli et al objects and by its centroid, that is the point to which the sum of distances from all objects in that cluster is minimized. Multiple regression analysis was carried out to determine the most important predictors of the ISR.
Statistical analyses were performed with the SPSS 13.0 statistical software system.
Results
To obtain groups numerically homogenous, the subjects were divided into quartiles according to their BMI. Demographic data and data on insulin sensitivity and secretion are reported in Table 1 .
Body composition analysis showed, as expected, a clear sexual dimorphism; therefore, the relative data are reported in Table 1 separately for men and women. However, insulin sensitivity and secretion as well as fasting plasma insulin and glucose levels and 2 h OGTT plasma glucose concentration did not differ significantly per gender, so that their data were polled together.
Insulin sensitivity progressively deteriorated with the increase of BMI, whereas the ISR increased.
A The best insulin-sensitivity variable between M/I/kg FFM and M/I/kg bw was the latter as shown by the area under the ROC curve (0.85 vs 0.89) (see Figure 1) .
Insulin resistance was defined as the lowest quartile of the distribution (that is, M/I/kg bw p29.3 mmol min À1 kg À1 nmol l À1 ) in the whole sample studied. The ability of the various indices as means for the identification of individuals with insulin resistance was assessed in the fourth quartile of the population using dicotomic variable (insulin resistance yes/no) as the outcome variable and insulin, HOMA, QUICKI, Matsuda index, and OGIS as the test variables. The areas under the curve and their 95% confidence interval shown in Table 2 suggest that the best surrogate indices of insulin sensitivity in the MO population are both the Matsuda index and OGIS. The worst prediction was obtained using fasting insulin levels and HOMA indices.
The whole-body glucose uptake declined exponentially with the increase of the BMI's quartiles as shown in Figure 2a , whereas the ISR (nmol m -2 ) linearly increased with the raise of the BMI (Figure 2b ).
An inverse exponential correlation between the log transformed ISR and glucose uptake was observed in the whole population (Figure 3 ). The quartile subgroups were fitted individually and the regression equations are given in the figure legend. The regression line was shifted progressively leftward and downward with increasing BMI, consistent with decreased b-cell function. However, the only statistical difference (Po0.05) for both slope and intercept was between the fourth and the first quartiles of BMI. The insulin secretion/insulin resistance index, proposed by Gastaldelli et al, 21 represents also a suitable model to correlate insulin sensitivity and secretion in MO subjects as shown in Figure 3 .
Discussion
The main findings of this study are that in MO subjects the values of insulin sensitivity, measured by the euglycemic hyperinsulinemic clamp, should be normalized by the BW rather than by the FFM; Fat mass and insulin sensitivity in morbid obesity D Gniuli et al the OGIS model gives the best results in alternative to the clamp; insulin sensitivity (M/I/kg bw ) declines with increase of BMI, whereas, on the contrary, ISR rises; in other words, M/I/kg bw correlates inversely with BMI, whereas ISR displays a direct relationship; the insulin secretion/insulin resistance index 21 represents a meaningful parameter also in morbid obesity.
Usually, the M-value, which represents the insulinmediated glucose uptake measured by the euglycemic clamp and which is currently considered the golden standard for insulin-sensitivity assessment, is normalized by the FFM. However, in MO subjects, the FM often reaches figures, which can even match those of FFM. For instance, in this study, the average FM in the fourth quartile, which includes MO subjects, was about 60 kg representing about 47% of the BW. Therefore, although the FFM is considered metabolically more active than FM, [22] [23] [24] which in non-obese subjects is not a major consumer of glucose, large amounts of FM cannot be ignored in terms of glucose metabolism in MO. In fact, it has been recently shown 25 that in MO subjects, the glucose uptake in the adipose tissue was comparable with the percentage of ingested carbohydrates taken up by the skeletal muscle tissue (17% vs 19% of the carbohydrates ingested with a test meal, respectively). In the aforementioned study, 25 the authors suggest that in morbid obesity the adipose tissue can provide a sink for the excess of glucose entering the circulation.
Further supporting this hypothesis, we have found that the ROC analysis showed that the most sensible and accurate method for measuring insulin sensitivity was the M-value normalized by the total BW instead of FFM.
Importantly, when compared with insulin-sensitivity measures obtained using the clamp technique, the best indices to identify MO people with insulin resistance were both Matsuda index and OGIS, whereas QUICKI, fasting insulin, and HOMA-IR were unsuitable indices. It is also important to note that both Matsuda index and OGIS represent a model, which reflects whole-body insulin sensitivity and, thus, they are the IS indices that are more closely linked to the clamp. In contrast, QUICKI, fasting insulin, and HOMA-IR are more related to the hepatic insulin sensitivity as they refer to fasting insulin and/or glucose levels. Our results suggest, therefore, that at least in MO subjects the best alternative to the euglycemic clamp are either the Matsuda index or the OGIS model.
According to Cnop et al, 26 the relationship between BMI and insulin sensitivity was found to be curvilinear, whereas the relationship between BMI and ISR was linear. Fat mass and insulin sensitivity in morbid obesity D Gniuli et al
Interestingly the correlation between BMI and insulin sensitivity, strictly resemble that of the insulin secretion/ insulin resistance index proposed by Gastaldelli et al, 21 which describes the dynamic interaction between insulin secretion and insulin resistance. A limitation of this study is that we have used the standard Du Bois equations to calculate BSA. However, at the moment this represents an unsolvable problem as it would be necessary to obtain a direct measure of the BSA in MO to calculate a predictive equation.
In conclusion, in MO subjects, in which the FM is highly represented, the FFM cannot be considered the only determinant of the insulin-mediated whole-body glucose uptake, thus the M-value should be normalized by the BW instead of FFM. In these subjects, the best surrogates of the insulin-sensitivity values measured by the euglycemic clamp are both Matsuda index and OGIS. Finally, insulin sensitivity decreases in a curvilinear manner with the increase of the BMI, whereas ISR increases linearly. In MO subjects, insulin secretion/insulin resistance index 21 is a valid parameter correlating ISR with insulin sensitivity. Fat mass and insulin sensitivity in morbid obesity D Gniuli et al
